Biohaven Ltd. - Common Stock (BHVN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
BHVN on NYSE
Shares outstanding
105,814,266
Price per share
$11.29
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
84,312,948
Total reported value
$1,263,794,324
% of total 13F portfolios
0%
Share change
-2,874,520
Value change
-$38,283,635
Number of holders
259
Price from insider filings
$11.29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Biohaven Ltd. - Common Stock (BHVN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 6.4% +30% $101,649,416 +$25,795,961 6,772,113 +34% JANUS HENDERSON GROUP PLC 30 Sep 2025
VANGUARD GROUP INC 2.7% $43,156,602 2,875,190 The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 259 institutional investors reported holding 84,312,948 shares of Biohaven Ltd. - Common Stock (BHVN). This represents 80% of the company’s total 105,814,266 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Biohaven Ltd. - Common Stock (BHVN) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.4% 7,874,891 +4.5% 0% $118,202,120
JANUS HENDERSON GROUP PLC 6.4% 6,772,113 +34% 0.05% $101,680,216
STIFEL FINANCIAL CORP 6.2% 6,611,350 +0.06% 0.09% $99,236,347
SUVRETTA CAPITAL MANAGEMENT, LLC 5.3% 5,620,271 0% 2.6% $84,360,268
STATE STREET CORP 4% 4,258,283 +20% 0% $63,916,828
VANGUARD GROUP INC 2.7% 2,875,190 -69% 0% $43,156,603
Bellevue Group AG 2.6% 2,802,853 0% 0.87% $42,070,824
FMR LLC 2.3% 2,426,904 +46% 0% $36,427,829
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,060,208 +1.4% 0% $30,928,678
PRICE T ROWE ASSOCIATES INC /MD/ 1.9% 2,009,611 -37% 0% $30,165,000
INFINITUM ASSET MANAGEMENT, LLC 1.6% 1,700,000 +209% 4.7% $25,517,000
GOLDMAN SACHS GROUP INC 1.5% 1,578,390 +61% 0% $23,691,633
JPMORGAN CHASE & CO 1.3% 1,335,455 -48% 0% $20,045,179
D. E. Shaw & Co., Inc. 1.2% 1,266,792 +144% 0.02% $19,014,548
Qube Research & Technologies Ltd 1.2% 1,265,597 +834% 0.03% $18,996,611
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.2% 1,260,033 +100% 0.03% $18,913,095
UBS Group AG 1.1% 1,119,665 +111% 0% $16,806,171
ARS Investment Partners, LLC 1% 1,102,549 -7.2% 1.1% $16,549,260
STEMPOINT CAPITAL LP 0.96% 1,017,311 +482% 3.1% $15,269,838
Capital Research Global Investors 0.96% 1,011,530 +109% 0% $15,183,065
CITADEL ADVISORS LLC 0.94% 997,793 +209% 0.01% $14,976,873
MILLENNIUM MANAGEMENT LLC 0.91% 968,153 -41% 0.01% $14,531,977
BNP PARIBAS FINANCIAL MARKETS 0.8% 843,564 0% 0.01% $12,661,896
TWO SIGMA INVESTMENTS, LP 0.76% 799,600 +986% 0.02% $12,001,996
JANE STREET GROUP, LLC 0.76% 799,278 +201% 0.01% $11,997,164

Institutional Holders of Biohaven Ltd. - Common Stock (BHVN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 185,394 $2,027,636 +$1,262,119 $11.29 11
2025 Q3 84,312,948 $1,263,794,324 -$38,283,635 $15.01 259
2025 Q2 86,987,421 $1,227,652,713 -$143,894,992 $14.11 247
2025 Q1 88,106,650 $2,142,495,070 -$115,214,537 $24.04 260
2024 Q4 89,346,784 $3,336,885,126 +$168,942,579 $37.35 253
2024 Q3 86,165,783 $4,306,353,110 +$148,383,281 $49.97 250
2024 Q2 82,422,187 $2,860,885,986 +$210,746,356 $34.71 222
2024 Q1 74,154,350 $4,055,673,624 +$161,363,053 $54.69 239
2023 Q4 71,802,540 $3,073,238,412 +$434,075,584 $42.80 214
2023 Q3 61,463,892 $1,598,669,852 +$39,755,212 $26.01 183
2023 Q2 60,120,418 $1,438,087,383 -$122,838,089 $23.92 183
2023 Q1 66,543,203 $909,962,550 +$54,642,668 $13.66 171
2022 Q4 62,449,262 $868,331,200 +$266,710,670 $13.88 168
2022 Q3 3,316,172 $499,083,000 +$491,524,000 $151.17 29
2022 Q2 $23.92 0